Prostate News Archive
10-Jun-2011
New Prostate Cancer Drugs Offer Hope
prostate cancer is the most common cancer among men, usually occurring at or after age 50, and the leading cause of death in men throughout the world. The cancer, which begins in the prostate gland of the male reproductive system, sometimes spreads to the bone and may be resistant to hormonal therapy. Prostate drugs raise risk of prostate cancer: FDA
A class of drugs meant to improve symptoms of an enlarged prostate gland actually increase the chance of getting a more serious form of prostate cancer, health officials said on Thursday. FDA: Prostate Cancer Risk From BPH, Hair Drugs
The prostate drugs Proscar, Avodart, and Jalyn and the hair-loss drug Propecia add to the risk of high-grade prostate cancer. FDA links some prostate drugs to cancer risk
The Food and Drug Administration expanded the warning label on a group of prostate drugs Thursday, saying they may increase the risk of a more serious form of prostate cancer. Drugs for benign prostate tumors increase the risk of aggressive cancers, FDA says
The Food and Drug Administration said Thursday it will require changes in the labeling of a family of drugs used to treat benign prostate hyperplasia to indicate that the drugs increase the risk of developing a more aggressive form of prostate cancer.
Back to Prostate News Archive
